Quality metrics for screening tests must evolve to mandate diagnostic resolution, ensuring financial and clinical incentives ...
Health systems and community practices strongly endorse partnership models, including after-hours triage, clinical training, ...
CAR T, bispecific antibodies, and oral CELMoDs—expand options, protect QOL, and raise hopes of cure, notes Asya Nina ...
At AMCP 2026, Kelsea Aragon, PharmD, discussed PrEP coverage, long-acting injectables, and payer strategies to improve HIV ...
Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results